Global Vigabatrin API Market Research Report 2025

Publication ID:

PB501254504

Publication Date:

February 5, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Vigabatrin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vigabatrin(CAS锛�60643-86-9) is a gamma-amino acid having a gamma-vinyl GABA structure.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vigabatrin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vigabatrin API.
The Vigabatrin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vigabatrin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vigabatrin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt Ltd
Divis Laboratories Ltd.
Granules India Limited
Guangzhou Tosun Pharmaceutical
by Type
Above 98 %
Above 99 %
by Application
Tablets
Oral Solution
Others
Production by Region
India
China
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vigabatrin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Vigabatrin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Vigabatrin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vigabatrin API Market Overview
1.1 Product Definition
1.2 Vigabatrin API by Type
1.2.1 Global Vigabatrin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Vigabatrin API by Application
1.3.1 Global Vigabatrin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Vigabatrin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Vigabatrin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Vigabatrin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Vigabatrin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Vigabatrin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Vigabatrin API, Industry Ranking, 2023 VS 2024
2.4 Global Vigabatrin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Vigabatrin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Vigabatrin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Vigabatrin API, Product Offered and Application
2.8 Global Key Manufacturers of Vigabatrin API, Date of Enter into This Industry
2.9 Vigabatrin API Market Competitive Situation and Trends
2.9.1 Vigabatrin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Vigabatrin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Vigabatrin API Production by Region
3.1 Global Vigabatrin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Vigabatrin API Production Value by Region (2020-2031)
3.2.1 Global Vigabatrin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Vigabatrin API by Region (2026-2031)
3.3 Global Vigabatrin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Vigabatrin API Production Volume by Region (2020-2031)
3.4.1 Global Vigabatrin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Vigabatrin API by Region (2026-2031)
3.5 Global Vigabatrin API Market Price Analysis by Region (2020-2025)
3.6 Global Vigabatrin API Production and Value, Year-over-Year Growth
3.6.1 India Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
4 Vigabatrin API Consumption by Region
4.1 Global Vigabatrin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Vigabatrin API Consumption by Region (2020-2031)
4.2.1 Global Vigabatrin API Consumption by Region (2020-2025)
4.2.2 Global Vigabatrin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Vigabatrin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Vigabatrin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Vigabatrin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Vigabatrin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Vigabatrin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Vigabatrin API Production by Type (2020-2031)
5.1.1 Global Vigabatrin API Production by Type (2020-2025)
5.1.2 Global Vigabatrin API Production by Type (2026-2031)
5.1.3 Global Vigabatrin API Production Market Share by Type (2020-2031)
5.2 Global Vigabatrin API Production Value by Type (2020-2031)
5.2.1 Global Vigabatrin API Production Value by Type (2020-2025)
5.2.2 Global Vigabatrin API Production Value by Type (2026-2031)
5.2.3 Global Vigabatrin API Production Value Market Share by Type (2020-2031)
5.3 Global Vigabatrin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Vigabatrin API Production by Application (2020-2031)
6.1.1 Global Vigabatrin API Production by Application (2020-2025)
6.1.2 Global Vigabatrin API Production by Application (2026-2031)
6.1.3 Global Vigabatrin API Production Market Share by Application (2020-2031)
6.2 Global Vigabatrin API Production Value by Application (2020-2031)
6.2.1 Global Vigabatrin API Production Value by Application (2020-2025)
6.2.2 Global Vigabatrin API Production Value by Application (2026-2031)
6.2.3 Global Vigabatrin API Production Value Market Share by Application (2020-2031)
6.3 Global Vigabatrin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hetero Drugs
7.1.1 Hetero Drugs Vigabatrin API Company Information
7.1.2 Hetero Drugs Vigabatrin API Product Portfolio
7.1.3 Hetero Drugs Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hetero Drugs Main Business and Markets Served
7.1.5 Hetero Drugs Recent Developments/Updates
7.2 Aurobindo Pharma Limited
7.2.1 Aurobindo Pharma Limited Vigabatrin API Company Information
7.2.2 Aurobindo Pharma Limited Vigabatrin API Product Portfolio
7.2.3 Aurobindo Pharma Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Aurobindo Pharma Limited Main Business and Markets Served
7.2.5 Aurobindo Pharma Limited Recent Developments/Updates
7.3 Intas Pharmaceuticals
7.3.1 Intas Pharmaceuticals Vigabatrin API Company Information
7.3.2 Intas Pharmaceuticals Vigabatrin API Product Portfolio
7.3.3 Intas Pharmaceuticals Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Intas Pharmaceuticals Main Business and Markets Served
7.3.5 Intas Pharmaceuticals Recent Developments/Updates
7.4 Metrochem API Private Limited
7.4.1 Metrochem API Private Limited Vigabatrin API Company Information
7.4.2 Metrochem API Private Limited Vigabatrin API Product Portfolio
7.4.3 Metrochem API Private Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Metrochem API Private Limited Main Business and Markets Served
7.4.5 Metrochem API Private Limited Recent Developments/Updates
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Vigabatrin API Company Information
7.5.2 SMS Pharmaceuticals Vigabatrin API Product Portfolio
7.5.3 SMS Pharmaceuticals Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 SMS Pharmaceuticals Main Business and Markets Served
7.5.5 SMS Pharmaceuticals Recent Developments/Updates
7.6 Biophore India Pharmaceuticals Pvt Ltd
7.6.1 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Company Information
7.6.2 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Portfolio
7.6.3 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served
7.6.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
7.7 Divis Laboratories Ltd.
7.7.1 Divis Laboratories Ltd. Vigabatrin API Company Information
7.7.2 Divis Laboratories Ltd. Vigabatrin API Product Portfolio
7.7.3 Divis Laboratories Ltd. Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Divis Laboratories Ltd. Main Business and Markets Served
7.7.5 Divis Laboratories Ltd. Recent Developments/Updates
7.8 Granules India Limited
7.8.1 Granules India Limited Vigabatrin API Company Information
7.8.2 Granules India Limited Vigabatrin API Product Portfolio
7.8.3 Granules India Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Granules India Limited Main Business and Markets Served
7.8.5 Granules India Limited Recent Developments/Updates
7.9 Guangzhou Tosun Pharmaceutical
7.9.1 Guangzhou Tosun Pharmaceutical Vigabatrin API Company Information
7.9.2 Guangzhou Tosun Pharmaceutical Vigabatrin API Product Portfolio
7.9.3 Guangzhou Tosun Pharmaceutical Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.9.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Vigabatrin API Industry Chain Analysis
8.2 Vigabatrin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Vigabatrin API Production Mode & Process Analysis
8.4 Vigabatrin API Sales and Marketing
8.4.1 Vigabatrin API Sales Channels
8.4.2 Vigabatrin API Distributors
8.5 Vigabatrin API Customer Analysis
9 Vigabatrin API Market Dynamics
9.1 Vigabatrin API Industry Trends
9.2 Vigabatrin API Market Drivers
9.3 Vigabatrin API Market Challenges
9.4 Vigabatrin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt Ltd
Divis Laboratories Ltd.
Granules India Limited
Guangzhou Tosun Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂